Sign in or Register

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >


Fig.1 Lymphoma

Lymphoma is a group of blood cell tumors that develop from lymphocytes. The name often refers to just the cancerous versions rather than all such tumors. Symptoms and signs and may include enlarged lymph nodes, fever, drenching sweats, unintended weight loss, itching, and constantly feeling tired. The two main categories of lymphomas are Hodgkin's lymphomas (HL) and the non-Hodgkin lymphomas (NHL). Around 90% of lymphomas are non-Hodgkin lymphomas. Lymphoma makes up 3–4% of all kinds of cancers, making them as a group of the seventh-most common form. As for the children, they are the third-most common cancer. Lymphoma can also spread to the central nervous system, often around the brain in the meninges, regarded as lymphomatous meningitis (LM). Diagnostic makers, like ZAP-70 expression, have been studied recently.